#CIVMs
🎓 Free CE credits available! Learn how to build scalable, reproducible 3D & organoid models for NAMs and CIVMs, including iPSC-derived neural, lung & cardiac organoids.

📅 Nov 5 | 10 AM PT / 1 PM ET

👉 Register:

buff.ly/vJWYcdw
November 4, 2026 at 5:07 PM
🎓 Free CE credits available! Learn how to build scalable, reproducible 3D & organoid models for NAMs and CIVMs, including iPSC-derived neural, lung & cardiac organoids.

📅 Nov 5 | 10 AM PT / 1 PM ET

👉 Register:

buff.ly/vJWYcdw
October 22, 2026 at 4:06 PM
Congratulations Dr. Zhu!

Yiguang Zhu successfully defended his dissertation: “Advancing Regulatory Acceptance of CIVMs: A Two-Phase Validation and Qualification Framework.

Yiguang celebrated with family, friends, colleagues, and his adviser, Paul Locke.
September 29, 2026 at 6:16 PM
Advanced tissue technologies of blood-brain barrier organoids as high throughput toxicity readouts in drug development #Heliyon #MassSpec www.cell.com/heliyon/full...
Advanced tissue technologies of blood-brain barrier organoids as high throughput toxicity readouts in drug development
Recent advancements in engineering Complex in vitro models (CIVMs) such as Blood-brain barrier (BBB) organoids offer promising platforms for preclinical drug testing. However, their application in dru...
www.cell.com
January 15, 2025 at 1:48 PM
💡 #PRIMTECH3R

#PRIMTECH3R is a project that aims to develop reliable mouse & human #CIVMs for preclinical studies, in order to replace, reduce and refine the use of animal models

🔗 Read more here by our project partner #EuroBioImaging: buff.ly/V875GTU

🧵 13/14
Developing new complex in vitro models for preclinical studies - PRIM-TECH3R
Developing new technologies and services for Research Infrastructures is one of our key priorities. Euro-BioImaging is partnering with fellow ERICs Infrafrontier and BBMRI in the framework of a new…
www.eurobioimaging.eu
May 22, 2025 at 7:14 AM
Advanced Tissue Technologies of Blood-Brain Barrier Organoids as High Throughput Toxicity Readouts in Drug Development https://www.biorxiv.org/content/10.1101/2024.09.09.611987v1
Advanced Tissue Technologies of Blood-Brain Barrier Organoids as High Throughput Toxicity Readouts in Drug Development https://www.biorxiv.org/content/10.1101/2024.09.09.611987v1
Recent advancements in engineering Complex in vitro models (CIVMs) such as Blood-brain barrier (BBB)
www.biorxiv.org
September 13, 2024 at 11:00 PM
Join the Special Edition #VirtualPub to learn more about the PRIM-TECH3R project which will work to develop reliable mouse & human CIVMs for preclinical studies, reducing the use of animal models.
🗓️ Jan 30 @ 1 pm CET
More 🔽
www.eurobioimaging.eu/news/introdu...
January 27, 2026 at 1:32 PM
#EuroBioImaging is delighted to be part of the #PRIMTECH3R project, led by #Infrafrontier, with partners @bbmrieric.bsky.social & 2 Nodes, @danishbioimaging.bsky.social & the Prague Node, to develop reliable mouse & human CIVMs for preclinical studies.
More 🔽
www.eurobioimaging.eu/news/develop...
Developing new complex in vitro models for preclinical studies - PRIM-TECH3R
Developing new technologies and services for Research Infrastructures is one of our key priorities. Euro-BioImaging is partnering with fellow ERICs Infrafrontier and BBMRI in the framework of a new EU...
www.eurobioimaging.eu
May 16, 2025 at 3:26 PM
(BioRxiv All) Advanced Tissue Technologies of Blood-Brain Barrier Organoids as High Throughput Toxicity Readouts in Drug Development: Recent advancements in engineering Complex in vitro models (CIVMs) such as Blood-brain barrier (BBB) organoids offer… http://dlvr.it/TDCppR #BioRxiv #MassSpecRSS
September 14, 2024 at 2:08 AM
Super interesting for those interested in NAMs and CIVMs
October 23, 2025 at 12:01 PM